封面
市場調查報告書
商品編碼
2158695

製藥配製系統市場:全球市場預測,2026-2032年

Drug Compounding System Market - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,藥品分發系統市場將成長至 27.2 億美元,複合年成長率為 9.40%。

主要市場統計數據
基準年 2025 14.5億美元
預計年份:2026年 15.8億美元
預測年份 2032 27.2億美元
複合年成長率 (%) 9.40%

藥品分發系統:執行摘要

當市售產品無法充分滿足病患需求時,藥物配發系統可輔助配製個人化藥物。該市場涵蓋醫院藥局、專業配藥機構和其他受監管醫療機構所使用的設備、軟體、耗材、工作流程管理及相關服務。其發展以藥物安全、無菌處理要求、藥劑師效率、可追溯性以及持續的品質保證為優先考慮因素。

更嚴格的監管和工作流程自動化正在改變處方藥的配發方式。

行業趨勢正朝著標準化、封閉式且日益自動化的工作流程轉變,以減少人工操作並提高可重複性。隨著監管機構對無菌配製、環境監測、文件記錄、操作人員能力和批次可追溯性的關注度不斷提高,醫療服務提供者正在推動流程現代化。與藥房系統、庫存管理系統和電子健康記錄系統的互通性也變得日益重要,同時,在人手不足和減少配藥錯誤的壓力日益增大的情況下,對技術驅動的檢驗和工作流程管理的需求也在不斷成長。

人工智慧(AI)增強了檢驗、規劃和品管。

人工智慧 (AI) 可透過輔助影像檢驗、異常檢測、劑量和成分檢查、庫存規劃以及預測性維護,為藥品分發做出貢獻。其實際價值取決於檢驗的數據、透明的決策邏輯、網路安全以及合格藥劑師的人工監督。因此,人工智慧最有意義的角色並非取代監管課責、臨床判斷或既定的品質體系,而是作為受控工作流程中的一個增強層。

區域差異反映了法規、基礎設施和醫療服務模式。

北美地區擁有成熟的藥房基礎設施,高度重視無菌配藥合規性,並廣泛採用自動化和電子追溯技術。在歐洲,先進的醫院系統以及詳盡的國家和歐洲法規要求,催生了對檢驗且可互通的解決方案的需求。亞太地區的應用情況差異很大,從高度發展的醫療環境到快速發展的藥房基礎設施,不一而足。拉丁美洲受到專業設施獲取管道不均、監管協調面臨挑戰以及日益成長的藥品安全擔憂的影響。中東地區正在增加對現代化醫療系統和集中式藥房營運的投資,而非洲則因資源限制、人才短缺以及醫院服務體系的擴張等因素,呈現出多樣化的需求。

經濟和安全夥伴關係會影響採購優先事項。

東協市場格局受監管成熟度、跨境供應考量以及不斷擴展的醫療基礎設施等方面的差異影響。金磚國家成員國在國內製造業、醫院現代化和藥品管理方面採取了不同的方法。歐盟受益於監管協調,但各國在具體實施上仍有差異。七國集團(G7)系統通常強調高度自動化、品管、資料整合和勞動效率。海灣合作理事會(GCC)國家正在發展由技術驅動的集中式醫療設施,並可能優先考慮可靠、高容量的藥房營運。北約成員國還面臨著與醫療用品持續供應、網路安全以及關鍵設備和耗材的可靠獲取相關的額外韌性考慮。

每個國家的實際情況都造就了其獨特的實施路徑。

澳洲和加拿大優先考慮其地理分散的醫療保健網路中醫院藥房的品質、員工效率和合規性。巴西和墨西哥面臨醫療保健現代化帶來的機遇,同時也面臨基礎設施和監管結構的區域差異。中國和印度正在提升其國家醫療保健能力,同時也要應對規模、監管複雜性和機構準備程度差異等問題。法國、德國、義大利、西班牙和英國將成熟的醫院系統與嚴格的文件記錄、無菌配製和專業課責要求相結合。日本和韓國強調精準性、品管和技術整合。俄羅斯的醫療保健環境受到醫療保健自給自足、供應連續性和監管要求的影響。美國則繼續專注於無菌配製管理、檢測準備、自動化和端到端可追溯性。

優先考慮檢驗的自動化、互通性和穩健的運作。

產業領導者必須確保產品開發符合公認的配藥標準、有據可查的驗證流程以及清晰的人工監督程序。解決方案必須在保持藥劑師控制權的同時減少人工干預,提供可審計的記錄,並與藥房和臨床資訊系統整合。各機構不僅應評估設備的功能,還應評估網路安全、資料管治、維護支援、培訓以及耗材的持續供應。區域部署策略應考慮當地法規、基礎設施可靠性、語言要求、服務交付能力以及人員技能水準。試驗計畫應採用可衡量的安全、效率、運轉率和品質指標,為計畫部署提供支援。

調查方法:對技術、法規和醫療保健服務進行實證審查。

本執行摘要採用結構化的定性分析方法,對目前藥品分發系統的現狀進行了評估。分析內容涵蓋分發設備和軟體功能、無菌配製和品質要求、醫療服務環境、自動化趨勢、互通性、人力資源挑戰以及特定地區、群體和國家的營運狀況。分析結果整合了成熟的行業概念以及公開記錄的監管和醫療系統相關考慮。本摘要不包含任何市場估算、預測、市場佔有率、預估或公司特定聲明。

藥房配藥系統正在轉向更安全、更一體化的工作流程。

市場的主要發展方向是將藥物安全管理、自動化、數位化追溯和穩健的藥房運作相結合。成功實施的關鍵不在於技術本身,而是檢驗的工作流程、法規遵循、熟練的人員、可靠的服務以及與現有系統的有效整合。那些將營運規範與人工智慧的負責任應用相結合,並制定區域性實施策略的領導企業,將在提高藥物配製的一致性、透明度和患者保護方面佔據優勢。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章:藥物配製系統市場:依類型分類

  • 非無菌
  • 無菌

第8章:藥物配製系統市場:依製劑類型分類

  • 注射藥物
  • 眼科
  • 口服製劑
  • 外用製劑

第9章:藥品配製系統市場:依服務模式分類

  • 內部
  • 外包
  • 單劑量製劑的生產

第10章:藥品分送系統市場:依分送類型分類

  • 生物製藥
    • 單株抗體
    • 疫苗
  • 荷爾蒙
  • 營養保健品
  • 低分子

第11章:製藥配製系統市場:依技術分類

  • 自動化系統
    • 條碼檢驗
    • 機器人輔助分發
  • 手動配藥
    • 手工製表
    • 人工稱重

第12章:製藥配製系統市場:依最終用戶分類

  • 門診手術中心
  • 診所
  • 家庭醫療保健
  • 醫院藥房
  • 零售藥房

第13章:製藥配製系統市場:依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章:製藥配製系統市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章:藥品配製系統市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2025年市佔率分析
  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第17章:公司簡介

  • ARxIUM, Inc.
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Capsa Healthcare, LLC
  • COMECER SpA
  • CURIFYLABS
  • EQUASHIELD
  • Fagron NV
  • Fresenius Kabi AG
  • Grifols, SA
  • ICU Medical, Inc.
  • Loccioni Group SpA
  • Medisca Pharmaceuticals, Inc.
  • Omnicell, Inc.
  • Professional Compounding Centers of America, Inc.
  • RxSafe, LLC
  • ScriptPro LLC
  • SMARTCOMPOUNDERS BV
  • Swisslog Healthcare GmbH

第18章 主要專家

Product Code: MRR-4654A89DBB92

The Drug Compounding System Market is projected to grow by USD 2.72 billion at a CAGR of 9.40% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.45 billion
Estimated Year [2026] USD 1.58 billion
Forecast Year [2032] USD 2.72 billion
CAGR (%) 9.40%

Drug Compounding Systems: Executive Summary

Drug compounding systems support the preparation of customized medications when commercially available products do not adequately meet patient needs. The market encompasses equipment, software, consumables, workflow controls, and related services used across hospital pharmacies, specialized compounding facilities, and other regulated care settings. Its development is shaped by medication-safety priorities, sterile-processing requirements, pharmacist productivity, traceability, and the need for consistent quality assurance.

Regulatory Rigor and Workflow Automation Are Reshaping Compounding

The landscape is shifting toward standardized, closed, and increasingly automated workflows that reduce manual handling and improve repeatability. Regulatory attention to sterile preparation, environmental monitoring, documentation, operator competency, and batch traceability is encouraging providers to modernize processes. Interoperability with pharmacy, inventory, and electronic health-record systems is also becoming more important, while labor shortages and pressure to reduce preparation errors are strengthening the case for technology-enabled verification and workflow management.

Artificial Intelligence Strengthens Verification, Planning, and Quality Control

Artificial intelligence can contribute to drug compounding by supporting image-based verification, anomaly detection, dose and ingredient checks, inventory planning, and predictive maintenance. Its practical value depends on validated data, transparent decision logic, cybersecurity, and human oversight by qualified pharmacy professionals. AI is therefore most relevant as an augmentation layer within controlled workflows rather than as a replacement for regulatory accountability, clinical judgment, or established quality systems.

Regional Differences Reflect Regulation, Infrastructure, and Care Delivery Models

North America is characterized by mature pharmacy infrastructure, strong emphasis on sterile-compounding compliance, and adoption of automation and electronic traceability. Europe combines advanced hospital systems with detailed national and European requirements, creating demand for validated and interoperable solutions. Asia-Pacific presents varied adoption conditions, ranging from highly sophisticated healthcare environments to rapidly developing pharmacy infrastructure. Latin America is influenced by uneven access to specialized facilities, regulatory harmonization challenges, and growing attention to medication safety. The Middle East is investing in modern healthcare capacity and centralized pharmacy operations, while Africa shows diverse needs shaped by resource constraints, workforce availability, and the expansion of organized hospital services.

Economic and Security Alliances Influence Procurement Priorities

ASEAN markets are shaped by differing regulatory maturity, cross-border supply considerations, and expanding healthcare infrastructure. BRICS members reflect varied approaches to domestic manufacturing, hospital modernization, and pharmaceutical control. The European Union benefits from regulatory coordination while retaining national implementation differences. G7 systems generally emphasize advanced automation, quality management, data integration, and workforce efficiency. GCC countries are developing centralized, technology-enabled healthcare facilities and may prioritize reliable, high-throughput pharmacy operations. NATO members face additional resilience considerations involving continuity of medical supply, cybersecurity, and dependable access to critical equipment and consumables.

Country Conditions Create Distinct Adoption Pathways

Australia and Canada emphasize hospital pharmacy quality, workforce efficiency, and compliance across geographically dispersed care networks. Brazil and Mexico face opportunities linked to healthcare modernization alongside regional disparities in infrastructure and oversight. China and India are advancing domestic healthcare capabilities while navigating scale, regulatory complexity, and varied institutional readiness. France, Germany, Italy, Spain, and the United Kingdom combine established hospital systems with strong requirements for documentation, sterile preparation, and professional accountability. Japan and South Korea emphasize precision, quality control, and technology integration. Russia's environment is influenced by healthcare self-reliance, supply continuity, and regulatory conditions. The United States remains strongly focused on sterile-compounding controls, inspection readiness, automation, and end-to-end traceability.

Prioritize Validated Automation, Interoperability, and Resilient Operations

Industry leaders should align product development with recognized compounding standards, documented validation, and clear human-oversight procedures. Solutions should reduce manual interventions while preserving pharmacist control, provide audit-ready records, and integrate with pharmacy and clinical information systems. Organizations should evaluate cybersecurity, data governance, maintenance support, training, and consumable continuity alongside equipment functionality. Regional deployment strategies should account for local regulations, infrastructure reliability, language requirements, service capacity, and workforce skills. Pilot programs with measurable safety, efficiency, uptime, and quality indicators can support disciplined implementation.

Methodology: Evidence-Based Review of Technology, Regulation, and Care Delivery

This executive summary uses a structured qualitative review of the drug compounding system landscape. The analysis considers the functions of compounding equipment and software, sterile-preparation and quality requirements, healthcare delivery settings, automation trends, interoperability, workforce pressures, and the operating conditions of the specified regions, groups, and countries. Insights are synthesized from established industry concepts and publicly documented regulatory and healthcare-system considerations. No market estimates, market shares, forecasts, or company-specific claims are used.

Drug Compounding Systems Are Moving Toward Safer, More Connected Workflows

The market's central direction is the integration of medication-safety controls, automation, digital traceability, and resilient pharmacy operations. Adoption will depend less on technology alone than on validated workflows, regulatory alignment, skilled personnel, dependable service, and effective integration with existing systems. Leaders that combine operational discipline with responsible use of AI and region-specific implementation strategies will be better positioned to improve consistency, transparency, and patient protection in compounded medication preparation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. New Revenue Opportunities
  • 3.4. Next-Generation Business Models
  • 3.5. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Drug Compounding System Market, by Type

  • 7.1. Introduction
  • 7.2. Non-Sterile
  • 7.3. Sterile

8. Drug Compounding System Market, by Formulation

  • 8.1. Introduction
  • 8.2. Injectables
  • 8.3. Ophthalmic
  • 8.4. Oral Preparations
  • 8.5. Topical Preparations

9. Drug Compounding System Market, by Service Model

  • 9.1. Introduction
  • 9.2. In-House
  • 9.3. Outsourced
  • 9.4. Unit Dose Manufacturing

10. Drug Compounding System Market, by Compound Type

  • 10.1. Introduction
  • 10.2. Biologic
    • 10.2.1. Monoclonal Antibody
    • 10.2.2. Vaccine
  • 10.3. Hormone
  • 10.4. Nutraceutical
  • 10.5. Small Molecule

11. Drug Compounding System Market, by Technology

  • 11.1. Introduction
  • 11.2. Automated Systems
    • 11.2.1. Barcode Verification
    • 11.2.2. Robotic Dispensing
  • 11.3. Manual Compounding
    • 11.3.1. Hand Tally
    • 11.3.2. Manual Weighing

12. Drug Compounding System Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Clinics
  • 12.4. Home Healthcare
  • 12.5. Hospital Pharmacies
  • 12.6. Retail Pharmacies

13. Drug Compounding System Market, by Region

  • 13.1. Introduction
  • 13.2. Asia-Pacific
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Europe
  • 13.6. Middle East
  • 13.7. Africa

14. Drug Compounding System Market, by Group

  • 14.1. Introduction
  • 14.2. ASEAN
  • 14.3. GCC
  • 14.4. European Union
  • 14.5. BRICS
  • 14.6. G7
  • 14.7. NATO

15. Drug Compounding System Market, by Country

  • 15.1. Introduction
  • 15.2. United States
  • 15.3. Canada
  • 15.4. Mexico
  • 15.5. Brazil
  • 15.6. United Kingdom
  • 15.7. Germany
  • 15.8. France
  • 15.9. Russia
  • 15.10. Italy
  • 15.11. Spain
  • 15.12. China
  • 15.13. India
  • 15.14. Japan
  • 15.15. Australia
  • 15.16. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. Market Concentration Analysis, 2025
    • 16.2.1. Concentration Ratio (CR)
    • 16.2.2. Herfindahl Hirschman Index (HHI)
  • 16.3. Recent Developments & Impact Analysis, 2025
  • 16.4. Product Portfolio Analysis, 2025
  • 16.5. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. ARxIUM, Inc.
  • 17.2. B. Braun Medical Inc.
  • 17.3. Baxter International Inc.
  • 17.4. Becton, Dickinson and Company
  • 17.5. Capsa Healthcare, LLC
  • 17.6. COMECER S.p.A.
  • 17.7. CURIFYLABS
  • 17.8. EQUASHIELD
  • 17.9. Fagron N.V.
  • 17.10. Fresenius Kabi AG
  • 17.11. Grifols, S.A.
  • 17.12. ICU Medical, Inc.
  • 17.13. Loccioni Group S.p.A.
  • 17.14. Medisca Pharmaceuticals, Inc.
  • 17.15. Omnicell, Inc.
  • 17.16. Professional Compounding Centers of America, Inc.
  • 17.17. RxSafe, LLC
  • 17.18. ScriptPro LLC
  • 17.19. SMARTCOMPOUNDERS B.V.
  • 17.20. Swisslog Healthcare GmbH

18. Key Experts

LIST OF FIGURES

  • FIGURE 1. Global Drug Compounding System Market, Years Considered for the Study
  • FIGURE 2. Global Drug Compounding System Market, Research Design
  • FIGURE 3. Global Drug Compounding System Market, Research Framework
  • FIGURE 4. Global Drug Compounding System Market, Data Triangulation
  • FIGURE 5. Global Drug Compounding System Market Size, 2017-2032 (USD Million)
  • FIGURE 6. Global Drug Compounding System Market Size, by Type, 2025 vs 2032 (%)
  • FIGURE 7. Global Drug Compounding System Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 8. Global Drug Compounding System Market Size, by Formulation, 2025 vs 2032 (%)
  • FIGURE 9. Global Drug Compounding System Market Size, by Formulation, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 10. Global Drug Compounding System Market Size, by Service Model, 2025 vs 2032 (%)
  • FIGURE 11. Global Drug Compounding System Market Size, by Service Model, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 12. Global Drug Compounding System Market Size, by Compound Type, 2025 vs 2032 (%)
  • FIGURE 13. Global Drug Compounding System Market Size, by Compound Type, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 14. Global Drug Compounding System Market Size, by Technology, 2025 vs 2032 (%)
  • FIGURE 15. Global Drug Compounding System Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 16. Global Drug Compounding System Market Size, by End User, 2025 vs 2032 (%)
  • FIGURE 17. Global Drug Compounding System Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 18. Global Drug Compounding System Market Size, by Region, 2025 vs 2032 (%)
  • FIGURE 19. Global Drug Compounding System Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 20. Global Drug Compounding System Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 21. Global Drug Compounding System Market Size, by Country, 2025 vs 2032 (%)
  • FIGURE 22. Global Drug Compounding System Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
  • FIGURE 23. Global Drug Compounding System Market Share, by Key Player, 2025

LIST OF TABLES

  • TABLE 1. Global Drug Compounding System Market Segmentation & Coverage
  • TABLE 2. Global Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 3. Global Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 4. Global Non-Sterile Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 5. Global Non-Sterile Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 6. Global Non-Sterile Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 7. Global Sterile Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 8. Global Sterile Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 9. Global Sterile Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 10. Global Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 11. Global Injectables Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 12. Global Injectables Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 13. Global Injectables Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 14. Global Ophthalmic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 15. Global Ophthalmic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 16. Global Ophthalmic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 17. Global Oral Preparations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 18. Global Oral Preparations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 19. Global Oral Preparations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 20. Global Topical Preparations Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 21. Global Topical Preparations Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 22. Global Topical Preparations Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 23. Global Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 24. Global In-House Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 25. Global In-House Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 26. Global In-House Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 27. Global Outsourced Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 28. Global Outsourced Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 29. Global Outsourced Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 30. Global Unit Dose Manufacturing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 31. Global Unit Dose Manufacturing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 32. Global Unit Dose Manufacturing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 33. Global Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 34. Global Biologic Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 35. Global Biologic Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 36. Global Biologic Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 37. Global Monoclonal Antibody Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 38. Global Monoclonal Antibody Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 39. Global Monoclonal Antibody Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 40. Global Vaccine Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 41. Global Vaccine Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 42. Global Vaccine Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 43. Global Hormone Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 44. Global Hormone Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 45. Global Hormone Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 46. Global Nutraceutical Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 47. Global Nutraceutical Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 48. Global Nutraceutical Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 49. Global Small Molecule Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 50. Global Small Molecule Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 51. Global Small Molecule Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 52. Global Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 53. Global Automated Systems Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 54. Global Automated Systems Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 55. Global Automated Systems Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 56. Global Barcode Verification Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 57. Global Barcode Verification Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 58. Global Barcode Verification Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 59. Global Robotic Dispensing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 60. Global Robotic Dispensing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 61. Global Robotic Dispensing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 62. Global Manual Compounding Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 63. Global Manual Compounding Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 64. Global Manual Compounding Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 65. Global Hand Tally Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 66. Global Hand Tally Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 67. Global Hand Tally Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 68. Global Manual Weighing Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 69. Global Manual Weighing Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 70. Global Manual Weighing Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 71. Global Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 72. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 73. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 74. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 75. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 76. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 77. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 78. Global Home Healthcare Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 79. Global Home Healthcare Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 80. Global Home Healthcare Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 81. Global Hospital Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 82. Global Hospital Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 83. Global Hospital Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 84. Global Retail Pharmacies Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 85. Global Retail Pharmacies Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 86. Global Retail Pharmacies Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 87. Global Drug Compounding System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 88. Asia-Pacific Drug Compounding System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 89. Asia-Pacific Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 90. Asia-Pacific Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 91. Asia-Pacific Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 92. Asia-Pacific Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 93. Asia-Pacific Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 94. Asia-Pacific Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 95. Asia-Pacific Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 96. Asia-Pacific Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 97. Asia-Pacific Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 98. North America Drug Compounding System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 99. North America Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 100. North America Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 101. North America Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 102. North America Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 103. North America Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 104. North America Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 105. North America Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 106. North America Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 107. North America Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 108. Latin America Drug Compounding System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 109. Latin America Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 110. Latin America Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 111. Latin America Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 112. Latin America Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 113. Latin America Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 114. Latin America Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 115. Latin America Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 116. Latin America Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 117. Latin America Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 118. Europe Drug Compounding System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 119. Europe Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 120. Europe Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 121. Europe Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 122. Europe Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 123. Europe Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 124. Europe Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 125. Europe Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 126. Europe Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 127. Europe Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 128. Middle East Drug Compounding System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 129. Middle East Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 130. Middle East Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 131. Middle East Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 132. Middle East Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 133. Middle East Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 134. Middle East Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 135. Middle East Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 136. Middle East Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 137. Middle East Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 138. Africa Drug Compounding System Market Size, by Region, 2017-2032 (USD Million)
  • TABLE 139. Africa Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 140. Africa Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 141. Africa Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 142. Africa Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 143. Africa Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 144. Africa Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 145. Africa Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 146. Africa Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 147. Africa Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 148. Global Drug Compounding System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 149. ASEAN Drug Compounding System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 150. ASEAN Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 151. ASEAN Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 152. ASEAN Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 153. ASEAN Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 154. ASEAN Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 155. ASEAN Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 156. ASEAN Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 157. ASEAN Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 158. ASEAN Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 159. GCC Drug Compounding System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 160. GCC Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 161. GCC Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 162. GCC Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 163. GCC Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 164. GCC Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 165. GCC Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 166. GCC Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 167. GCC Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 168. GCC Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 169. European Union Drug Compounding System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 170. European Union Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 171. European Union Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 172. European Union Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 173. European Union Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 174. European Union Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 175. European Union Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 176. European Union Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 177. European Union Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 178. European Union Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 179. BRICS Drug Compounding System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 180. BRICS Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 181. BRICS Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 182. BRICS Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 183. BRICS Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 184. BRICS Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 185. BRICS Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 186. BRICS Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 187. BRICS Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 188. BRICS Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 189. G7 Drug Compounding System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 190. G7 Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 191. G7 Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 192. G7 Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 193. G7 Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 194. G7 Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 195. G7 Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 196. G7 Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 197. G7 Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 198. G7 Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 199. NATO Drug Compounding System Market Size, by Group, 2017-2032 (USD Million)
  • TABLE 200. NATO Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 201. NATO Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 202. NATO Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 203. NATO Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 204. NATO Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 205. NATO Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 206. NATO Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 207. NATO Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 208. NATO Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 209. Global Drug Compounding System Market Size, by Country, 2017-2032 (USD Million)
  • TABLE 210. United States Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 211. United States Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 212. United States Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 213. United States Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 214. United States Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 215. United States Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 216. United States Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 217. United States Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 218. United States Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 219. United States Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 220. Canada Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 221. Canada Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 222. Canada Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 223. Canada Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 224. Canada Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 225. Canada Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 226. Canada Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 227. Canada Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 228. Canada Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 229. Canada Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 230. Mexico Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 231. Mexico Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 232. Mexico Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 233. Mexico Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 234. Mexico Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 235. Mexico Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 236. Mexico Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 237. Mexico Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 238. Mexico Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 239. Mexico Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 240. Brazil Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 241. Brazil Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 242. Brazil Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 243. Brazil Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 244. Brazil Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 245. Brazil Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 246. Brazil Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 247. Brazil Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 248. Brazil Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 249. Brazil Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 250. United Kingdom Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 251. United Kingdom Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 252. United Kingdom Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 253. United Kingdom Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 254. United Kingdom Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 255. United Kingdom Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 256. United Kingdom Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 257. United Kingdom Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 258. United Kingdom Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 259. United Kingdom Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 260. Germany Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 261. Germany Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 262. Germany Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 263. Germany Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 264. Germany Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 265. Germany Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 266. Germany Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 267. Germany Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 268. Germany Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 269. Germany Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 270. France Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 271. France Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 272. France Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 273. France Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 274. France Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 275. France Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 276. France Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 277. France Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 278. France Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 279. France Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 280. Russia Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 281. Russia Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 282. Russia Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 283. Russia Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 284. Russia Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 285. Russia Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 286. Russia Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 287. Russia Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 288. Russia Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 289. Russia Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 290. Italy Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 291. Italy Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 292. Italy Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 293. Italy Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 294. Italy Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 295. Italy Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 296. Italy Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 297. Italy Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 298. Italy Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 299. Italy Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 300. Spain Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 301. Spain Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 302. Spain Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 303. Spain Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 304. Spain Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 305. Spain Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 306. Spain Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 307. Spain Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 308. Spain Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 309. Spain Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 310. China Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 311. China Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 312. China Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 313. China Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 314. China Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 315. China Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 316. China Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 317. China Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 318. China Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 319. China Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 320. India Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 321. India Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 322. India Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 323. India Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 324. India Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 325. India Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 326. India Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 327. India Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 328. India Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 329. India Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 330. Japan Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 331. Japan Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 332. Japan Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 333. Japan Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 334. Japan Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 335. Japan Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 336. Japan Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 337. Japan Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 338. Japan Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 339. Japan Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 340. Australia Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 341. Australia Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 342. Australia Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 343. Australia Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 344. Australia Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 345. Australia Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 346. Australia Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 347. Australia Drug Compounding System Market Size, by Automated Systems, 2017-2032 (USD Million)
  • TABLE 348. Australia Drug Compounding System Market Size, by Manual Compounding, 2017-2032 (USD Million)
  • TABLE 349. Australia Drug Compounding System Market Size, by End User, 2017-2032 (USD Million)
  • TABLE 350. South Korea Drug Compounding System Market Size, 2017-2032 (USD Million)
  • TABLE 351. South Korea Drug Compounding System Market Size, by Type, 2017-2032 (USD Million)
  • TABLE 352. South Korea Drug Compounding System Market Size, by Formulation, 2017-2032 (USD Million)
  • TABLE 353. South Korea Drug Compounding System Market Size, by Service Model, 2017-2032 (USD Million)
  • TABLE 354. South Korea Drug Compounding System Market Size, by Compound Type, 2017-2032 (USD Million)
  • TABLE 355. South Korea Drug Compounding System Market Size, by Biologic, 2017-2032 (USD Million)
  • TABLE 356. South Korea Drug Compounding System Market Size, by Technology, 2017-2032 (USD Million)
  • TABLE 357. South Korea Drug Compo